Risk factors of familial pancreatic cancer in Japan: Current smoking and recent onset of diabetes

Pancreas

Volumn 40, Issue 6, 2011, Pages 974-978

  Matsubayashi, Hiroyuki ^a   Maeda, Atsuyuki ^a   Kanemoto, Hideyuki ^a   Uesaka, Katsuhiko ^a   Yamazaki, Kentaro ^a   Hironaka, Shuichi ^a   Miyagi, Yuji ^a   Ikehara, Hisatomo ^a   Ono, Hiroyuki ^a   Klein, Alison ^b   Goggins, Michael ^b  

^a SHIZUOKA CANCER CENTER   (Japan)

^b DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

early detection; familial pancreatic cancer; family history; Japan; pancreatic cancer; risk factor

Indexed keywords

ADULT; ALCOHOL CONSUMPTION; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DEMOGRAPHY; DIABETES MELLITUS; FAMILIAL CANCER; FAMILY HISTORY; FEMALE; HUMAN; JAPAN; MAJOR CLINICAL STUDY; MALE; PANCREAS CANCER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RELATIVE; RISK ASSESSMENT; SMOKING; SMOKING HABIT;

AGE OF ONSET; AGED; CASE-CONTROL STUDIES; DIABETES COMPLICATIONS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; JAPAN; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PANCREATIC NEOPLASMS; RISK FACTORS; SMOKING;

EID: 80051545326     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e3182156e1b     Document Type: Article

References (46)

1. Japan Pancreatic Society. Summary of 20 years. Pancreatic cancer registry of Japan Pancreas Society. J Jpn Panc Soc. 2003;18(1):101-169 [in Japanese with English abstract].
2. Canto MI. Strategies for screening for pancreatic adenocarcinoma in high-risk patients. Semin Oncol. 2007;34:295-302. (Pubitemid 47176623)
3. Rulyak SJ, Kimmey MB, Veenstra DL, et al. Cost-effectiveness of pancreatic cancer screening in familial pancreatic cancer kindreds. Gastrointest Endosc. 2003;57:23-29. (Pubitemid 36236794)
4. Langer P, Kann PH, Fendrich V, et al. Five years of prospective screening of high-risk individuals from families with familial pancreatic cancer. Gut. 2009;58:1410-1418.
5. Tada M, Kawabe T, Arizumi M, et al. Pancreatic cancer in patients with pancreatic cystic lesions: A prospective study in 197 patients. Clin Gastroenterol Hepatol. 2006;4:1265-1270. (Pubitemid 44512221)
6. Tanaka S, Nakaizumi A, Ioka T, et al. Main pancreatic duct dilatation: A sign of high risk for pancreatic cancer. Jpn J Clin Oncol. 2002; 32:407Y411.
7. Tanno S, Nakano Y, Koizumi K, et al. Pancreatic ductal adenocarcinomas in long-term follow-up patients with branch duct intraductal papillary mucinous neoplasms. Pancreas. 2010;39:36-40.
8. Malka D, Hammel P, Maire F, et al. Risk of pancreatic adenocarcinoma in chronic pancreatitis. Gut. 2002;51:849-852. (Pubitemid 35408607)
9. Ye W, Lagergren J, Nyren O, et al. Risk of pancreatic cancer after cholecystectomy: A cohort study in Sweden. Gut. 2001;49:678-681. (Pubitemid 32989205)
10. Ye W, Lagergren J, Weiderpass E, et al. Alcohol abuse and the risk of pancreatic cancer. Gut. 2002;51:236-239. (Pubitemid 34791453)
11. Lowenfels AB, Maisonneuve P. Epidemiology and prevention of pancreatic cancer. Jpn J Clin Oncol. 2004;34:238-244. (Pubitemid 43102883)
12. Matsubayashi H, Skinner HG, Iacobuzio-Donahue C, et al. Pancreaticobiliary cancers with deficient methylenetetrahydrofolate reductase genotypes. Clin Gastroenterol Hepatol. 2005;3:752-760. (Pubitemid 41116727)
13. Ogawa Y, Tanaka M, Inoue K, et al. A prospective pancreatographic study of the prevalence of pancreatic carcinoma in patients with diabetes mellitus. Cancer. 2002;94:2344-2349. (Pubitemid 34457114)
14. Stolzenberg-Solomon RZ, Adams K, Leitzmann M, et al. Adiposity, physical activity, and pancreatic cancer in the National Institutes of HealthYAARP Diet and Health Cohort. Am J Epidemiol. 2008;167:586-597. (Pubitemid 351323320)
15. Lynch HT, Deters CA, Lynch JF, et al. Familial pancreatic carcinoma in Jews. Fam Cancer. 2004;3:233-240.
16. Stolzenberg-Solomon RZ, Cross AJ, Silverman DT, et al. Meat and meat-mutagen intake and pancreatic cancer risk in the NIH-AARP cohort. Cancer Epidemiol Biomarkers Prev. 2007;16:2664-2675. (Pubitemid 351196322)
17. Alguacil J, Porta M, Benavides FG, et al. Occupation and pancreatic cancer in Spain: A case-control study based on job titles. PANKRAS II Study Group. Int J Epidemiol. 2000;29:1004-1013. (Pubitemid 32040802)
18. Andreotti G, Freeman LE, Hou L, et al. Agricultural pesticide use and pancreatic cancer risk in the Agricultural Health Study Cohort. Int J Cancer. 2009;124:2495-2500.
19. Giardiello FM, Brensinger JD, Tersmette AC, et al. Very high risk of cancer in familial Peutz-Jeghers syndrome. Gastroenterology. 2000;119:1447Y1453.
20. Whitcomb DC, Applebaum S, Martin SP. Hereditary pancreatitis and pancreatic carcinoma. Ann N Y Acad Sci. 1999;880:201-209. (Pubitemid 29349128)
21. Neglia JP, FitzSimmons SC, Maisonneuve P, et al. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med. 1995;332:494-499.
22. Giardiello FM, Offerhaus GJ, Lee DH, et al. Increased risk of thyroid and pancreatic carcinoma in familial adenomatous polyposis. Gut. 1993;34:1394-1396. (Pubitemid 23293626)
23. Klein AP, Brune KA, Petersen GM, et al. Prospective risk of pancreatic cancer in familial pancreatic cancer kindreds. Cancer Res. 2004;64:2634-2638. (Pubitemid 38523922)
24. James TA, Sheldon DG, Rajput A, et al. Risk factors associated with earlier age of onset in familial pancreatic carcinoma. Cancer. 2004;101:2722-2726. (Pubitemid 39603179)
25. Lynch HT, Deters CA, Snyder CL, et al. BRCA1 and pancreatic cancer: Pedigree findings and their causal relationships. Cancer Genet Cytogenet. 2005;158:119-125. (Pubitemid 40417693)
26. McWilliams RR, Rabe KG, Olswold C, et al. Risk of malignancy in first-degree relatives of patients with pancreatic carcinoma. Cancer. 2005;104:388-394. (Pubitemid 40993268)
27. Martin ST, Matsubayashi H, Rogers CD, et al. Increased prevalence of the BRCA2 polymorphic stop codon K3326X among individuals with familial pancreatic cancer. Oncogene. 2005;24:3652-3656. (Pubitemid 40756234)
28. Rieder H, Sina-Frey M, Ziegler A, et al. German national case collection of familial pancreatic cancerVclinical-genetic analysis of the first 21 families. Onkologie. 2002;25:262-266. (Pubitemid 34765273)
29. McFaul CD, Greenhalf W, Earl J, et al. Anticipation in familial pancreatic cancer. Gut. 2006;55:252-258. (Pubitemid 43117286)
30. Wang W, Chen S, Brune KA, et al. PancPRO: Risk assessment for individuals with a family history of pancreatic cancer. J Clin Oncol. 2007;25:1417Y1422.
31. Greenhalf W, Malats N, Nilsson M, et al. International registries of families at high risk of pancreatic cancer. Pancreatology. 2008;8:558-565.
32. Yeo TP, Hruban RH, Brody J, et al. Assessment of "gene- environment" interaction in cases of familial and sporadic pancreatic cancer. J Gastrointest Surg. 2009;13:1487Y1494.
33. Reddy NK, Bhutani MS. Racial disparities in pancreatic cancer and radon exposure: A correlation study. Pancreas. 2009;38:391-395.
34. Couch FJ, Johnson MR, Rabe KG, et al. The prevalence of BRCA2 mutations in familial pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2007;16:342-346. (Pubitemid 46383356)
35. Inoue M, Tajima K, Takezaki T, et al. Epidemiology of pancreatic cancer in Japan: A nested case-control study from the Hospital-based Epidemiologic Research Program at Aichi Cancer Center (HERPACC). Int J Epidemiol. 2003;32:257Y262.
36. Permuth-Wey J, Egan KM. Family history is a significant risk factor for pancreatic cancer: Results from a systematic review and meta-analysis. Fam Cancer. 2009;8:109-117.
37. Wang L, Brune KA, Visvanathan K, et al. Elevated cancer mortality in the relatives of patients with pancreatic cancer. Cancer Epidemiol Biomarkers Prev. 2009;18:2829-2834.
38. Chari ST, Leibson CL, Rabe KG, et al. Probability of pancreatic cancer following diabetes: A population-based study. Gastroenterology. 2005;129:504-511. (Pubitemid 41096638)
39. Pelaez-Luna M, Takahashi N, Fletcher JG, et al. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: A retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol. 2007;102:2157Y2163.
40. Murphy KM, Brune KA, Griffin C, et al. Evaluation of candidate genes MAP2K4, MADH4, ACVR1B, and BRCA2 in familial pancreatic cancer: Deleterious BRCA2 mutations in 17%. Cancer Res. 2002; 62:3789-3793. (Pubitemid 34728862)
41. Goggins M, Schutte M, Lu J, et al. Germline BRCA2 gene mutations in patients with apparently sporadic pancreatic carcinomas. Cancer Res. 1996;56:5360-5364. (Pubitemid 27011364)
42. Bartsch DK, Sina-Frey M, Lang S, et al. CDKN2A germline mutations in familial pancreatic cancer. Ann Surg. 2002;236:730-737. (Pubitemid 35403228)
43. Mantelli M, Barile M, Ciotti P, et al. High prevalence of the G101W germline mutation in the CDKN2A (P16(ink4a)) gene in 62 Italian malignant melanoma families. Am J Med Genet. 2002;107:214-221. (Pubitemid 34044893)
44. Eberle MA, Pfutzer R, Pogue-Geile KL, et al. A new susceptibility locus for autosomal dominant pancreatic cancer maps to chromosome 4q32-34. Am J Hum Genet. 2002;70:1044-1048. (Pubitemid 34259323)
45. Jones S, Hruban RH, Kamiyama M, et al. Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science. 2009;324:217.
46. Brune KA, Lau B, Palmisano E, et al. Importance of age of onset in pancreatic cancer kindreds. J Natl Cancer Inst. 2010;102:119-126.